Compare Tango Therapeutics Inc. (TNGX) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs Energy Select Sector SPDR Fund — how do they compare? Tango Therapeutics Inc. trades at $22.23 (market cap $3.75B), while Energy Select Sector SPDR Fund trades at $67.7 (market cap $42.98B). The key difference: Energy Select Sector SPDR Fund is far larger — about 11.5× Tango Therapeutics Inc.'s market cap, and Energy Select Sector SPDR Fund is trading nearer its 52-week high, Tango Therapeutics Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tango Therapeutics Inc. for 0 Days and Energy Select Sector SPDR Fund for 68 Days on average.
| TNGX | XLE | |
|---|---|---|
Market Cap | $3.75B | $42.98B |
Volume | 9,619,106 | 27,490,546 |
Sector | Health | — |
52-Week High | $32.90 | $67.61 |
52-Week Low | $7.50 | $42.64 |
Typical Hold Time | 0 Days | 68 Days |
Enterprise Value | $2.77B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
XLE trades at $67.17, up 1.74% on the day, with a bullish technical signal driven by moving averages and strong momentum indicators. The ETF's performance is closely tied to oil price dynamics, with recent news highlighting supply disruptions and geopolitical tensions supporting energy sector strength. Key support lies near $65, while resistance is seen around $67.
Outlook remains positive near-term due to oil market tightness, but risks include potential price reversals and sector volatility. Investors should weigh the ETF's concentrated oil and gas exposure against broader energy infrastructure alternatives for diversified income and stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
